Integrated Metabolomics and Lipidomics Analyses Reveal Metabolic Reprogramming in Human Glioma with IDH1 Mutation
文献类型：期刊论文
| 作者 | Xu, Guowang1; Zhou, Lina1; Wang, Zhichao1,2; Hu, Chunxiu1; Zhang, Chaoqi3; Kovatcheva-Datchary, Petia1; Yu, Di1,2; Liu, Shasha3; Ren, Feifei3; Wang, Xiaolin1 |
| 刊名 | JOURNAL OF PROTEOME RESEARCH
 |
| 出版日期 | 2019-03-01 |
| 卷号 | 18期号:3页码:960-969 |
| ISSN号 | 1535-3893 |
| 关键词 | glioma IDH1 metabolomics lipidomics metabolic reprogramming |
| DOI | 10.1021/acs.jproteome.8b00663 |
| 通讯作者 | Zhang, Yi(yizhang@zzu.edu.cn) ; Xu, Guowang() |
| 英文摘要 | Mutations in isocitrate dehydrogenase (IDH) 1 are high-frequency events in low-grade glioma and secondary glioblastoma, and IDH1 mutant gliomas are vulnerable to interventions. Metabolic reprogramming is a hallmark of cancer. In this study, comprehensive metabolism investigation of clinical IDH1 mutant glioma specimens was performed to explore its specific metabolic reprogramming in real micro environment. Massive metabolic alterations from glycolysis to lipid metabolism were identified in the IDH1 mutant glioma tissue when compared to IDH1 wild-type glioma. Of note, tricarboxylic acid (TCA) cycle intermediates were in similar levels in both groups, with more pyruvate found entering the TCA cycle in IDH1 mutant glioma. The pool of fatty acyl chains was also reduced, displayed as decreased triglycerides and sphingolipids, although membrane phosphatidyl lipids were not changed. The lower fatty acyl pool may be mediated by the lower protein expression levels of long-chain acyl-CoA synthetase 1 (ACSL1), ACSL4, and very long-chain acyl-CoA synthetase 3 (ACSVL3) in IDH1 mutant glioma. Lower ACSL1 was further found to contribute to the better survival of IDH1 mutant glioma patients based on the The Cancer Genome Atlas (TCGA) RNA sequencing data. Our research provides valuable insights into the tissue metabolism of human IDH1 mutant glioma and unravels new lipid-related targets. |
| WOS关键词 | ISOCITRATE DEHYDROGENASE 1 ; OXIDATIVE STRESS ; R132H MUTATION ; CANCER ; PROFILES ; GROWTH ; CELLS |
| 资助项目 | National Natural Science Foundation of China[81472374] ; National Natural Science Foundation of China[21505132] ; National Natural Science Foundation of China[21435006] ; [2017YFC0906900] |
| WOS研究方向 | Biochemistry & Molecular Biology |
| 语种 | 英语 |
| 出版者 | AMER CHEMICAL SOC |
| WOS记录号 | WOS:000460491800014 |
| 资助机构 | National Natural Science Foundation of China ; National Natural Science Foundation of China ; National Natural Science Foundation of China ; National Natural Science Foundation of China ; National Natural Science Foundation of China ; National Natural Science Foundation of China ; National Natural Science Foundation of China ; National Natural Science Foundation of China |
| 源URL | [http://cas-ir.dicp.ac.cn/handle/321008/165894]  |
| 专题 | 大连化学物理研究所_中国科学院大连化学物理研究所 |
| 通讯作者 | Xu, Guowang; Zhang, Yi |
| 作者单位 | 1.Chinese Acad Sci, Dalian Inst Chem Phys, CAS Key Lab Separat Sci Analyt Chem, Dalian 116023, Peoples R China 2.Univ Chinese Acad Sci, Beijing 100049, Peoples R China 3.Zhengzhou Univ, Affiliated Hosp 1, Biotherapy Ctr, Zhengzhou 450052, Henan, Peoples R China |
| 推荐引用方式 GB/T 7714 | Xu, Guowang,Zhou, Lina,Wang, Zhichao,et al. Integrated Metabolomics and Lipidomics Analyses Reveal Metabolic Reprogramming in Human Glioma with IDH1 Mutation[J]. JOURNAL OF PROTEOME RESEARCH,2019,18(3):960-969. |
| APA | Xu, Guowang.,Zhou, Lina.,Wang, Zhichao.,Hu, Chunxiu.,Zhang, Chaoqi.,...&Zhang, Yi.(2019).Integrated Metabolomics and Lipidomics Analyses Reveal Metabolic Reprogramming in Human Glioma with IDH1 Mutation.JOURNAL OF PROTEOME RESEARCH,18(3),960-969. |
| MLA | Xu, Guowang,et al."Integrated Metabolomics and Lipidomics Analyses Reveal Metabolic Reprogramming in Human Glioma with IDH1 Mutation".JOURNAL OF PROTEOME RESEARCH 18.3(2019):960-969. |
入库方式： OAI收割
来源：大连化学物理研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。